MedPath

Quantification of Autonomic Nervous Activity During Hemodialysis

Not Applicable
Completed
Conditions
Chronic Kidney Disease on Hemodialysis
Interventions
Other: Analysis of the holter electrocardiogram
Registration Number
NCT02754986
Lead Sponsor
University of Hyogo
Brief Summary

This study assesses autonomic nervous system function by power spectral analysis of RR interval dynamics in ultrafiltration subjects without blood pressure variation.

Detailed Description

Variations over time in autonomic nervous activity due to differences in ultrafiltration rate will be evaluated by measuring heart rate variability in hemodialysis patients without blood pressure variations during HD session.

The subjects will be divided into 3 groups, those with UFR \< 10 ml/hr/kg; ≥10 ml/hr/kg but ≤ 15 ml/hr/kg; and \>15 ml/hr/kg, and Holter ECG are recorded continuously during HD session using frequency analysis of RR intervals.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Patients with stable undergoing hemodialysis without hanging in blood pressure during hemodialysis.
Exclusion Criteria
  • Patients with chronic atrial fibrillation
  • Patients with frequent ventricular premature beats
  • Patients with a permanent pacemaker
  • Patients with taking antihypertensive drugs
  • Patients with medical treatment due to changes in blood pressure

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
measuring Holter electrocardiogramAnalysis of the holter electrocardiogramHotter ECG will be recorded continuously during hemodialysis
Primary Outcome Measures
NameTimeMethod
The outcome measures was low frequency power (LF, ms2) to high frequency power (HF, ms2) ratio (LF/HF ratio) of heart rate variability. The three subject groups with difference ultrafiltration were compared by LF/HF ratio during hemodialysis session.4 hours

Variations over time in autonomic nervous activity due to differences in ultrafiltration rate will be evaluated by measuring heart rate variability.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Graduate School of Applied Informatics, University of Hyogo

🇯🇵

Kobe, Hyogo, Japan

© Copyright 2025. All Rights Reserved by MedPath